Beta-2-microglobulin (B2M) was first discovered in 1964 in the urine of patients with Wilson’s disease and cadmium poisoning, a histocompatibility complex class I (MHC-I) molecule expressed on almost all nucleated cells (8). Here, B2M is linked to Wilson disease.